Cardiology

The CVD-REAL 2 study found that compared with other glucose-lowering drugs, SGLT-2 inhibitors reduce all-cause death, hospitalization for heart failure, myocardial infarction, and stroke.

While receiving a large dose of statin therapy did not have an impact on major adverse cardiac events among a broad population of patients, those that underwent percutaneous coronary intervention saw reductions.

Patients that were more optimistic had fewer heart-related hospital visits.

The mSToPS trial revealed a wearable ECG patch can markedly increase the AFib diagnosis rate relative to routine care—as much as 9-fold in the short-term and 3-fold in the long-term.

MOMENTUM 3 found that advanced heart-failure patients with an implanted centrifugal-flow circulatory pump had lower rates of pump-related blood clots and stroke.

Studies reveal short- and long-term effects of heart changes in college and professional football players.

The use of instantaneous wave-free ratio can reportedly save each patient at least $800 in comparison with fractional flow reserve.

While full parity may be impossible, a 4-step protocol did decrease discrepancies in clinical outcomes and mortality between men and women.

Clinicians have been shown to be influenced by their patients’ genetic makeup when prescribing antiplatelet therapies.

All-cause mortality and death due to stroke, however, were 1.8% and 0.5% lower, respectively, in the group utilizing WCD.

Study sheds new light on potential risks and benefits of aspirin for people with both conditions.

The trial showed alirocumab reduced MACE by 24% with an ARR of 3.4% and all-cause death by 29% with an ARR of 1.7% in patients with ACS and baseline LDL-C ≥100 mg/dL.

The therapies come on the tail of Amgen's failed attempt to receive a 6-month exclusivity extension for Sensipar.

Significant discrepancies are found between ASCVD guidelines and primary care management of HIV patients in the military health system.

Will results of a study comparing a new formula for evaluating LDL-C in the nonfasting state and the Friedewald method turn heads?

The expanded approval of the heart valve makes it the smallest mechanical heart valve approved in the world, a size small enough to be used in newborn pediatric patients to treat heart defects.

Despite prior evidence showing that those with CVD live longer if they are overweight or obese at the time of diagnosis leading to confusion, new data has shed light on why this paradox exists.

Varicose veins were rarely thought to have severe health effects, but should now be monitored closely, new evidence suggests.

This meta-analysis does not provide support for current recommendations to use omega-3 fatty acid supplements for the prevention of cardiovascular disease risk.

They were also 3 times more likely to suffer from cancer, and reported a greater rate of hypertension and cardiovascular disease.

Medtronic had both its Guardian Sensor 3 CGM system and it's Resolute Onyx 2.0 mm drug-eluting stent approved by the FDA.

Study data revealed that the patients who received a 2-week course of the antibiotic observed an unexpected increase in death.

Black patients had a 62% greater chance of having experienced an ischemic stroke pre-AF diagnosis, and a 67% higher risk of having one post-AF diagnosis.

Weight from age 25 onwards has been linked to the risk of more or less heart damage, as measured by levels of the protein troponin, underscoring the importance of long-term weight control.

In a story written by Jackie MacMullan and published on ESPN.com, it was revealed the Hall of Fame basketball player Nate “Tiny” Archibald has been living with amyloidosis.

A new study identified 6 ECG features that warn of potentially fatal cardiac arrhythmia in adults presenting with syncope.

The rate comes in spite of the fact that women are more likely to report more heart attack-associated symptoms, and to have been treated for such symptoms previously, than men.

Patients taking ustekinumab showed a 19% improvement in aortic inflammation compared to placebo.

The CRL identified deficiencies related to the chemistry, manufacturing and control and flagged certain safety concerns about the concentration contained in the formula.